• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,922.64 443.97
( 0.58%)
Global Indices
Nasdaq
52,316.93 113.19
(0.22%)
Dow Jones
7,516.83 55.40
(0.74%)
Hang Seng
70,577.01 514.69
(0.73%)
Nikkei 225
10,511.26 27.04
(0.26%)
Forex
USD-INR
94.49 0.37
(0.39%)
EUR-INR
107.78 0.64
(0.60%)
GBP-INR
125.01 0.85
(0.69%)
JPY-INR
0.58 0.00
(0.33%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
375.7814421
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
35.18
113252.99
EPS(TTM)
Face Value()
Div & Yield %
38.57
1
0.59
 

Rajasthan Securities standalone net profit rises 9025.37% in the March 2026 quarter
May 29,2026
Net profit of Rajasthan Securities rose 9025.37% to Rs 61.14 crore in the quarter ended March 2026 as against Rs 0.67 crore during the previous quarter ended March 2025. Sales reported to Rs 61.21 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025.

For the full year,net profit rose 1055.35% to Rs 80.99 crore in the year ended March 2026 as against Rs 7.01 crore during the previous year ended March 2025. Sales reported to Rs 61.21 crore in the year ended March 2026. There were no Sales reported during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales61.210 0 61.210 0
OPM %94.940 -54.960 -
PBDT72.971.69 4218 104.348.03 1199
PBT72.941.69 4216 104.318.03 1199
NP61.140.67 9025 80.997.01 1055